Novo Nordisk A/S ADR (USD)
NVO
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range56.85 | 57.32
52-Wk Range43.60 | 58.01
Last Close57.25
Mkt Cap (m)133,670.83
Dividend yield1.38%
ISINUS6701002056
Volume209,680
Exchange VenueNYS

Company Profile

Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company's business segments include, diabetes and obesity care, and biopharmaceuticals.

Key Information
Price/Earning23.71
Price/Book17.06
Price/Sales7.70
P/CF18.73
Rev Growth (3 year avg)1.19
EPS Growth (3 year avg)0.06
Operating Margin % 42.25
Net Margin %34.54
Return on Equity76.00
Debt/Equity0.01

Legal Documents

Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)83,57288,806107,927111,780111,696111,831
Operating Income (m)31,49334,49249,44448,43248,96747,248
Net Income (m)25,18426,48134,86037,92538,13038,628
Basic EPS9.4010.1013.5614.9915.4215.96
Avg. Diluted Shares Outstanding (m)2,6942,6302,5782,5352,4782,424
Balance Sheet
USD201320142015201620172018
Current Assets (m)42,05846,29355,14059,76660,08059,067
Non Current Assets (m)28,27930,76936,65937,77342,27551,702
Total Assets (m)70,33777,06291,79997,539102,355110,769
Current Liabilities (m)24,22533,68940,87347,43647,05654,164
Total Liabilities (m)------
Total Equity (m)42,56940,29446,96945,26949,81551,839
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)25,94231,69238,28748,31441,16844,616
Capital Expenditure (m)-3,644-4,335-6,406-8,267-8,648-12,410
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
57.25
Last Price